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Abstract
Background: In Tanzania, less than a third of HIV infected children estimated to be in need of antiretroviral therapy 
(ART) are receiving it. In this setting where other infections and malnutrition mimic signs and symptoms of AIDS, early 
diagnosis of HIV among HIV-exposed infants without specialized virologic testing can be a complex process. We aimed 
to introduce an Early Infant Diagnosis (EID) pilot program using HIV DNA Polymerase Chain Reaction (PCR) testing with 
the intent of making EID nationally available based on lessons learned in the first 6 months of implementation.
Methods: In September 2006, a molecular biology laboratory at Bugando Medical Center was established in order to 
perform HIV DNA PCR testing using Dried Blood Spots (DBS). Ninety- six health workers from 4 health facilities were 
trained in the identification and care of HIV-exposed infants, HIV testing algorithms and collection of DBS samples. 
Paper-based tracking systems for monitoring the program that fed into a simple electronic database were introduced 
at the sites and in the laboratory. Time from birth to first HIV DNA PCR testing and to receipt of test results were 
assessed using Kaplan-Meier curves.
Results: From October 2006 to March 2007, 510 HIV-exposed infants were identified from the 4 health facilities. Of 
these, 441(87%) infants had an HIV DNA PCR test at a median age of 4 months (IQR 1 to 8 months) and 75(17%) were 
PCR positive. Parents/guardians for a total of 242(55%) HIV-exposed infants returned to receive PCR test results, 
including 51/75 (68%) of those PCR positive, 187/361 (52%) of the PCR negative, and 4/5 (80%) of those with 
indeterminate PCR results. The median time between blood draw for PCR testing and receipt of test results by the 
parent or guardian was 5 weeks (range <1 week to 14 weeks) among children who tested PCR positive and 10 weeks 
(range <1 week to 21 weeks) for those that tested PCR negative.
Conclusions: The EID pilot program successfully introduced systems for identification of HIV-exposed infants. There 
was a high response as hundreds of HIV-exposed infants were registered and tested in a 6 month period. Challenges 
included the large proportion of parents not returning for PCR test results. Experience from the pilot phase has 
informed the national roll-out of the EID program currently underway in Tanzania.
Background
There is increasing availability of antiretroviral treatment
(ART) for adults and children in Tanzania but by Decem-
ber 2008, only 13,400 (32%) of the 42,000 children esti-
mated to be eligible for ART were receiving treatment
[1,2]. Infants and young children with HIV infection are
at high risk for rapid disease progression and death [3-6],
implying an urgent need to identify and enroll them into
HIV care and treatment programs so that ART can be
started at the earliest opportunity. Unfortunately, simple
antibody-based diagnosis of HIV infection in infants is
complicated by passive transfer of maternal HIV antibod-
ies during pregnancy. More sophisticated molecular bio-
logic tests such as those using polymerase chain reaction
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(PCR) technology are needed to distinguish HIV infected
from HIV exposed but uninfected children during the
first 1-2 years of life [7-9]. Clinical and immunologic cri-
teria can be used for presumptive diagnosis of HIV infec-
tion for the purpose of starting ART [10], but these have
low sensitivity and specificity [11,12] and symptoms of
HIV infection can be difficult to distinguish from those of
other prevalent conditions in uninfected children such as
malnutrition and tuberculosis.
Until recently laboratory capacity for program-level
PCR-based assays has been limited in Sub-Saharan Africa
and lacking in Tanzania, resulting in a significant barrier
to early infant diagnosis (EID) and timely initiation of
ART in HIV-infected infants [10]. The increasing avail-
ability of these assays at lower prices and the high sensi-
tivity of HIV DNA PCR testing using Dried Blood Spots
(DBS) have made it feasible to develop national EID pro-
grams in several Sub-Saharan African countries [7,13-16].
We introduced a pilot EID program in the Lake region of
Tanzania (Figure 1) aiming to establish laboratory capac-
ity and infrastructure to perform HIV DNA PCR testing;
and to develop clinical infrastructure and systems to sup-
port identification, care and follow-up of HIV-exposed
infants in both remote rural and moderately urban set-
t i n g s .  W e  r e p o r t  o n  t h e  e x p e r i e n c e  o f  d e v e l o p i n g  a n d
establishing the EID program, describe the characteris-
tics of children served, and report on successes and chal-
lenges of the pilot phase in order to inform the on-going
scale up of EID services in Tanzania and Sub-Saharan
Africa.
Methods
The EID program was collaboratively designed and
implemented by the International Center for AIDS Care
and Treatment Programs (ICAP), the Tanzanian Ministry
of Health and Social Welfare, Bugando Medical Centre
(BMC) and the United States Centers for Disease Control
and Prevention (CDC). The steps taken in establishment
of the EID program are described below and summarized
in Table 1.
Community preparation and site selection
Prior to program initiation, community and religious
leaders as well as health officials at the district (e.g. Dis-
Figure 1 Map of Tanzania showing the location of the Early Infant Diagnosis (EID) pilot program activities.
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Table 1: Approaches to the critical processes of setting up the Early Infant Diagnosis (EID) program in Tanzania, outcomes 
observed and challenges encountered
Process Approach Outcomes observed Challenges encountered
Community 
preparation:
-Engaged communities before services were 
introduced.
-Targeted influential community leaders for 
community advocacy.
-Utilized community gatherings for mass 
communication.
-Created anticipation for the 
services.
-Community members encouraged 
to access services.
-Quickly informed many 
community members.
-Community members expected 
same-day test results and not to 
have to return for results at a later 
visit.
Health facility 
selection:
-Selected sites with existing PMTCT* programs and 
maternal child health clinics.
-There was a ready need for EID** 
services which then easily 
integrated.
-Some PMTCT programs were not 
functioning optimally in providing 
HIV testing and counseling and 
PMTCT antiretroviral regimens.
-Infant follow-up was not a 
consistent component of all PMTCT 
programs.
Health facility 
preparation:
-Sensitized all health facility staff to refer possible HIV-
exposed infants for EID services.
-Identified space where EID services would be offered.
-Worked with health facility staff to create and 
implement a detailed practical plan on how services 
would be offered.
-Implemented a system for transporting samples from 
the site to the laboratory and results delivery back to 
the site.
-Children were referred from many 
service delivery points.
-Streamlined registration and 
follow-up of HIV-exposed infants.
-Streamlined delivery of services.
-Established sample transportation 
and results delivery systems.
-Health workers had multiple 
competing responsibilities.
-Maintaining efficiency of the 
sample transportation and results 
delivery system.
Capacity 
building:
-Conducted didactic training complemented with on-
site mentorship.
-Empowered health workers and 
allowed them to develop 
confidence to implement services.
-Ensured supervision in the early 
phases of implementation.
-Linked didactic training to 
implementation.
-Transfer of trained personnel to 
other departments, facilities or 
regions. Request for financial 
incentives by health workers.
Laboratory 
establishment:
-Renovated an existing zonal laboratory that served 
multiple sites within the catchment area.
-Trained laboratory staff at a laboratory with 
established PCR facilities.
-Provided expert mentorship and on-going regular 
supervision at the laboratory.
-Conducted quality assurance assessments according 
to standard procedures.
-Minimized start-up costs.
-Laboratory staff gained a practical 
view of how systems work.
-Ensured continuity of quality PCR 
services.
-Ensuring continuous supply of 
materials and supplies for DNA PCR 
testing.
-Lab personnel had competing 
responsibilities.
Defining the 
HIV testing 
algorithm:
-Done at national level with involvement of key 
stakeholders including the Ministry of Health and 
donors.
-Promoted national and 
stakeholder acceptance of the 
testing algorithm.
-Reaching agreement on an 
algorithm that was both cost-
effective but clinically relevant.
Registration 
and follow-up 
HIV-exposed 
infants and data 
collection:
-Created specific tools for recording data related to 
HIV-exposed infants and PCR testing.
-Developed standard operating procedures for the 
new clinical services.
-Registered HIV-exposed infants prior to availability of 
EID services were available.
-Provided comprehensive follow-up care (e.g. giving 
cotrimoxazole).
-Due to limited resources, preferentially followed-up 
infants that tested DNA PCR positive through 
appointment cards, phone calls and home visits.
-Monitoring and evaluation 
systems were readily available for 
the national roll-out.
-Ensured HIV-exposed infants were 
being identified, registered and 
provided with necessary services.
-Ensured that those at the greatest 
risk of mortality (HIV-infected 
infants) were referred to the HIV 
care and treatment clinic.
-Health services poorly equipped 
to retain infants for longitudinal 
follow-up.
-High rate of loss to follow-up to 
obtain for DNA PCR results.
-Some mothers stopped 
breastfeeding after first negative 
PCR result.
-High rate of loss to follow-up to 
obtain final infection status after 
breast feeding cessation.
*PMTCT = Prevention of Mother to Child HIV Transmission; **EID = Early Infant DiagnosisNuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
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trict Medical Officers, District Reproductive Health Ser-
vices Coordinator and District AIDS Coordinators) and
regional levels (Regional AIDS Coordinator) were sensi-
tized through meetings at which the planned EID pro-
gram was explained by ICAP staff. These staff also spoke
at church and mosque gatherings to inform the commu-
nities about the availability, importance and benefits of
the EID program.
Four health facilities were purposively selected to
reflect a variety of settings and included two regional
hospitals, one zonal hospital which also housed the PCR
laboratory, and one health centre in the Lake region of
Tanzania (Figure 1). The first regional hospital was 208
km away from the laboratory, the second regional hospi-
tal was 8.6 km away and the health centre 11 km away.
The selected health facilities had antenatal care clinics
with well-established Prevention of Mother-to-Child HIV
Transmission (PMTCT) programs where in total more
than 7,000 pregnant women were counseled and tested
for HIV annually following the national and World
Health Organization (WHO) PMTCT guidelines at that
time [17,18]. The 2 regional hospitals and the zonal hos-
pital had HIV care and treatment clinics (CTCs) within
the hospital complex. HIV infected women from the
health centre were referred to the nearby regional hospi-
tal (within 2 km) for CTC services.
Health facility preparation and staff capacity building
Existing health facility staff working in PMTCT clinics,
maternity wards, pediatric clinics and pediatric wards as
well as CTCs were informed of the upcoming EID pro-
gram and their input sought during the planning phase.
Staff began to track and register HIV-exposed infants
from the sites and the community several months prior to
the availability of DNA PCR testing. At each of the 4 pilot
sites, an EID room was identified where counseling and
DBS sampling could be conducted. At the regional hospi-
tals and the health centre, the EID room was co-located
within the antenatal PMTCT clinic, while at the zonal
hospital; it was situated within the pediatric ward. Health
facility staff were instructed to refer all HIV-exposed
infants from their service delivery points to the EID room
for DBS sampling. Each health facility defined patient
flow patterns as a strategy to maximize identification,
registration and testing of HIV-exposed infants.
A total of 96 health workers from the 4 health facilities
including nurses, counselors, community health workers,
clinicians, and laboratory staff received 2-day didactic
training followed by 2 weeks of on-site supervision and
mentorship. The training curriculum included identifica-
tion of HIV-exposed infants, the HIV testing algorithm
and interpretation of PCR results, DBS collection and the
use of a paper-based data collection and monitoring sys-
tem. Elements of HIV-exposed infant care including cot-
rimoxazole prophylaxis, growth monitoring, infant
feeding, long-term follow-up until determination of final
infection status and referral to CTCs for those HIV
infected were emphasized during the training.
Laboratory establishment
A molecular biology laboratory at BMC was established
b y  r e n o v a t i o n  o f  t h e  e x i s t i n g  c l i n i c a l  l a b o r a t o r y  a n d
installation of PCR equipment. Two BMC lab staff
received 4 weeks of training at the Government of
Rwanda's National Reference Laboratory in Kigali fol-
lowed by 4 weeks on-site supervision by an experienced
laboratory advisor. Roche Amplicor v 1.5 DNA PCR kits
(Roche Diagnostics, Inc., Alameda, CA) were procured
and used as described by Sherman et al [7]. Internal qual-
ity control panels containing negative and high positive
(5,000 proviral copies of HIV/ml) DBS were obtained
from CDC's Global AIDS Program International Labora-
tory Branch in Atlanta. The results obtained were inter-
preted following the kit instructions. Every 3 months, all
positive samples and 10% of the negative samples were re-
tested for quality assurance. All samples with indetermi-
nate results were repeat tested using the same sample,
and an additional sample collected from the HIV-exposed
infant at a follow-up visit. Data on HIV DNA PCR labora-
tory activities were recorded in a paper-based register
and entered into a simple electronic (Microsoft Access)
database.
HIV testing algorithm and definitions
The HIV-exposed infant testing algorithm was deter-
mined in collaboration with the Government of Tanza-
nia's Ministry of Health. Rapid HIV antibody screening
was conducted on the infants of mothers with unknown
HIV status. All children <18 months of age who either
were HIV antibody positive or were born to a known HIV
positive woman were defined as HIV-exposed infants. All
parents and guardians of HIV-exposed infants were
counseled on HIV DNA PCR testing and all HIV-exposed
infants were tested unless the parent or guardian declined
the test. The first DNA PCR testing was scheduled for 6
weeks of age, the time at which most infants in Tanzania
received their first set of routine vaccinations. All HIV-
exposed infants less than 18 months of age who had not
had a previous HIV DNA PCR test were eligible for PCR
testing. DBS were collected by heel, toe or finger stick,
dried on a rack and then stored in an envelope with anti-
humidity pellets according to standard procedures [7].
Infants testing positive at the first PCR test were defined
as HIV-infected [19], had a DBS collected for a second
(confirmatory) PCR test, and were referred to the CTC
on the same day that the first PCR test results were given
to parents or guardians. Infants testing PCR negative
were followed clinically and tested again using HIV rapidNuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
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antibody tests at least 6 weeks after weaning. Infants with
initial negative PCR tests who developed clinical symp-
toms were eligible for repeat PCR testing.
Registration, care and follow-up of HIV-exposed infants
HIV-exposed infants were registered in the EID room by
recording key data in paper-based registers including a
unique identifier, date of birth, gender, contact details,
PMTCT prophylaxis taken by the mother and baby, HIV
testing details and medications given. HIV-exposed
infants who were 6 weeks or older were started on cotri-
moxazole prophylaxis. Once a week, an EID nurse or cou-
rier service transported the DBS samples to the PCR
laboratory and collected and delivered the previous
week's results. Parents and guardians were given appoint-
ment cards and asked to return to the clinic 1 month after
DBS collection to receive DNA PCR results and to refill
cotrimoxazole prescriptions. If parents/guardians did not
return to the clinic within 28 days of the scheduled
appointment, contact tracing by phone and home visits
was done by ICAP staff and health facility EID nurses in
collaboration with community outreach groups. Due to
the limited resources, staff prioritized visits to children
testing PCR positive.
Data collection and analysis
A paper-based system using longitudinal HIV-exposed
infant registers and lab registers was implemented, and
captured key information including date of birth,
PMTCT prophylaxis, and HIV testing details. Standard
Operating Procedures on how, when, and where to
record the required data elements were availed to sites for
reference. Data from the HIV-exposed infant registers
were entered into an electronic database and updated
monthly by ICAP staff. These routinely collected service
delivery data from the HIV-exposed infant register data-
base with updates through June 2007 were de-identified
and analyzed using SAS version 9.1. The outcomes of
interest were: time from birth to blood draw for the first
HIV DNA PCR test, time from this blood draw to receipt
of PCR test results by the parent/guardian and the pro-
portion of parents/guardians receiving PCR test results.
Characteristics of HIV-exposed infants were described in
frequency tables and categorical variables were compared
using chi-square statistics and time to events examined
using stratified Kaplan-Meier curves. Parents/guardians
that did not return for PCR test results were censored at
the end of the data collection period in June 2007. This
program was part of a larger HIV care and treatment pro-
gram in Tanzania which received non-research determi-
nation from the Columbia University Institutional
Review Board. Routinely collected data from the program
were de-identified and analyzed for purposes of program
evaluation so no consent was sought from participants.
Results
From October 2006 to March 2007, 510 HIV-exposed
infants (median age: 4 months, IQR: 1 to 8 months) were
identified and registered. Table 2 summarizes the charac-
teristics of these infants, 441 (86%) of whom were tested
with DNA PCR. There were statistically significant differ-
ences between children who were tested with DNA PCR
(n = 441) and the untested children (n = 69) on several
characteristics. As expected because the testing algo-
rithm recommended DNA PCR testing from 6 weeks,
90% of the untested children were less than 6 weeks of age
at presentation, compared with 13% of those tested (p <
0.01). Ninety three percent of those untested were
referred from PMTCT clinics and enrolled at one
Regional Hospital. Tested children were more likely than
those untested to initiate cotrimoxazole (98% vs 78%, p <
0.01), but more untested children and/or their mothers
had received PMTCT prophylaxis, 91% vs 65% of those
tested, p < 0.01. At the time of database closure, infant
feeding data were incomplete and therefore excluded
from this analysis.
Among those tested (n = 441), the median age at first
HIV DNA PCR testing was 4 months, IQR: 1 to 8 months,
with no statistically significant differences in time to PCR
testing between HIV-exposed infants who tested PCR
positive and those who tested PCR negative (Figure 2). Of
the 441 HIV-exposed infants tested, 75 (17%) were PCR
positive, 361 tested PCR negative, and 5 (1%) had indeter-
minate test results (Table 2). The 5 infants with indeter-
m i n a t e  f i r s t  D N A  P C R  t e s t  r e s u l t s  w e r e  t e s t e d  a t  a
median age of 7 weeks. Only 48% of the infants testing
PCR positive were exposed to PMTCT prophylaxis
(mother and/or infant had received ART for PMTCT)
compared to 68% of those testing negative (p < 0.01).
A total of 242/441 (55%) HIV-exposed infants' parents/
guardians returned for follow-up to learn the PCR test
results, including 51/75 (68%) of the PCR positive chil-
dren, 187/361 (52%) of the PCR negative children and 4/5
(80%) of those with indeterminate PCR results. The
median time between blood draw for PCR testing and
receipt of test results by the parent or guardian was 5
weeks (range <1 week to 14 weeks) among children who
tested PCR positive and 10 weeks (range <1 week to 21
weeks) for those that tested PCR negative (Figure 3).
Seven of the 52 DNA PCR positive infants whose par-
ents/guardians received results had died by the time test
results returned. Of the 45 infants who received results,
42 (93%) were referred to CTC, and all received a second
DNA PCR test which was positive, confirming HIV infec-
tion. The other 3/45 infants died before they were
referred to the CTC.
Of the 361 infants who tested DNA PCR negative, 108
(30%) were no longer breastfeeding at the time of testing.Nuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
http://www.biomedcentral.com/1471-2431/10/44
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Table 2: Characteristics of HIV-exposed infants tested and not tested for HIV by DNA PCR, and of infants testing PCR 
positive and PCR negative in the Tanzania Early Infant Diagnosis (EID) pilot program
HIV-exposed
infants not
tested
HIV-exposed
infants
tested*
Total p-value§ Infants with a
 positive first
DNA PCR *
Infants with a
negative first
DNA PCR *
p-value§
n = 69 (%) n = 441(%) n = 510 (%) n = 75 (%) n = 361 (%)
Gender
Male 16(23%) 252(57%) 268 (53%) <0.01 45(60%) 206(57%) 0.82
Female 8(12%) 188(43%) 196 (38%) 30(40%) 154(43%)
Missing data 45(65%) 1(0%) 46(9%) 0(0%) 1(0%)
Age at registration β
Less than 6 weeks 62(90%) 57(13%) 119 (23%) <0.01 10(13%) 46(13%) 0.22
6 weeks - < 6 months 2(3%) 218(49%) 220 (43%) 36(48%) 179(50%)
6 months - < 12 
months
1(1%) 108(25%) 109 (21%) 14(19%) 93(26%)
≥ 12 months 4(6%) 58(13%) 62 (12%) 15(20%) 43(12%)
Initiated cotrimoxazole prophylaxis
Yes 54(78%) 432(98%) 486 (95%) <0.01 75(100%) 352(98%) 0.18
No 9(13%) 9(2%) 18 (4%) 0(0%) 9(2%)
Missing data 6(9%) 0(0%) 6(1%) 0(0%) 0(0%)
Health facility where EID€ services 
were received
Regional Hospital 1 0(0%) 93(21%) 93 (18%) <0.01 14(19%) 76(21%) 0.75
Regional Hospital 2 59(86%) 122(28%) 181 (35%) 18(24%) 103(29%)
Zonal Hospital 1(1%) 140(32%) 141 (28%) 27(36%) 112(31%)
Health Centre 9(13%) 86(20%) 95(19%) 16(21%) 70(19%)
Referral source of HIV-exposed infants
HIV Care and 
Treatment Clinic (CTC)
2(3%) 205(47%) 207 (41%) <0.01 35(47%) 169(47%) 0.11
PMTCT/Maternal Child 
Health clinics
64(93%) 197(45%) 261 (51%) 29(39%) 165(46%)
Other 3(4%) 39(9%) 42 (8%) 11(15%) 27(7%)
PMTCT ARV's π received by infants
Single-dose 
Nevirapine
60(87%) 270(61%) 330 (65%) <0.01 34(45%) 232(64%) <0.01
None 9(13%) 171(39%) 180 (35%) 41(55%) 129(36%)
PMTCT ARV's π received by mothers
Highly Active 
Antiretroviral Therapy
1(1%) 11(2%) 12 (2%) 0.16 0(0%) 10(3%) 0.04
Single-dose 
Nevirapine
24(35%) 203(46%) 227 (45%) 27(37%) 173(48%)
None 44(64%) 227(52%) 271 (53%) 48(64%) 178(49%)Nuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
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The other 253 children were expected to return for anti-
body testing after weaning, but only 42 (17%) had
returned for testing by the time of this analysis. All but 3
(6.7%) of these 42 children tested antibody negative. The
3 who tested antibody positive also had a positive second
DNA PCR test, which confirmed HIV infection. All the 4
children with indeterminate results at first DNA PCR
testing who returned for results had a second DNA PCR
test: 3 were PCR negative and 1 PCR positive at the sec-
ond test.
Discussion and Conclusion
This was the first service delivery program (outside of
research initiatives) established for reliable HIV diagnosis
among infants in Tanzania, and the only HIV DNA PCR
service in the Lake Region. In addition to providing HIV
diagnostic capacity, the introduction of PCR laboratory
services stimulated the development and institutionaliza-
tion of clinical programs for HIV-exposed infant follow-
up. In the first 6 months of implementation, systems were
established to identify HIV-exposed infants and engage
them in care. This was a major success in a setting with
no previous clear linkages between PMTCT programs
and HIV-exposed infant follow-up, and no systems to
diagnose HIV infection in infants prior to their presenta-
tion with symptoms of advanced HIV disease. The hun-
dreds of HIV-exposed infants identified in a short period,
33% of whom were 6 months or older and the median age
of testing at 4 months are a reflection of the back-log of
un-tested infants in this community that lacked EID ser-
vices prior to this program. Kenya observed a similar
median age at PCR testing as services were rolled out [20]
and similar high uptake of the program was observed in
Botswana when the EID program was implemented in
two large cities [13].
The first 6 months of implementing the EID program
demonstrated other important successes. Life saving cot-
rimoxazole was initiated for the majority of the HIV-
exposed infants enrolled in our EID program. There was
a rapid turnaround time with many parents/guardian
receiving PCR test results within a median of 5 weeks
(PCR positive) and 10 weeks (PCR negative) after testing,
demonstrating some similarities with what was observed
in the Kenyan program [20]. This was facilitated by hav-
ing a clearly outlined sample and results tracking and
delivery system and was a significant improvement from
the many months of waiting needed for the antibody test
to reliably reflect HIV status. As programs scale up, less
attention tends to be paid to this aspect leading to delay
in return and utilization of results [21] and sample turn-
around time can be a significant program barrier with
long delays of several months. Another success was the
development of EID standard operating procedures and
training materials that gave guidance to the national EID
program roll-out [22].
Challengingly, only 55% of the parents/guardians
returned for PCR test results. Such significant attrition of
HIV-exposed infants has been noted by other programs
in sub-Saharan Africa [8,14,21,23], yet retaining children
in care is essential to prevent mortality [24]. More par-
Both mother and infant received 
PMTCT ARV's π
Yes 22 (32%) 198 (45%) 220 (43%) 0.04 25(33%) 169(47%) 0.03
No 47 (68%) 243 (55%) 290 (57%) 50(67%) 192(53%)
Mother and/or infant received PMTCT 
ARV's π
Yes 63(91%) 286(65%) 349(68%) <0.01 36(48%) 246(68%) <0.01
No 6(9%) 155(35%) 161(32%) 39(52%) 115(32%)
Parent/guardian received DNA PCR 
results
Yes n/a 238(55%)* n/a 51(68%) 187 (52%) 0.01
No 198(45%) 24(32%) 174(48%)
*5 HIV-exposed infants with indeterminate results at first DNA PCR testing are excluded from this table, 4 of whom returned for PCR test results
§ P-values are from Pearson's chi-square tests
β Age that the status of being HIV-exposed was first recognised and formally recorded for follow-up
€ EID = Early Infant Diagnosis
π PMTCT ARV's = Prevention of Mother to Child HIV Transmission Anti Retroviral Therapy
Table 2: Characteristics of HIV-exposed infants tested and not tested for HIV by DNA PCR, and of infants testing PCR 
positive and PCR negative in the Tanzania Early Infant Diagnosis (EID) pilot program (Continued)Nuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
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ents and guardians of infants testing PCR positive
returned for results likely because of the preferential fol-
low-up by staff through community tracking and home
visits. Also, more than 70% of children appeared to be
still breastfeeding by the time of these analyses and the
continued exposure to HIV warrants that children receive
regular monitoring visits and repeat testing to determine
final infection status. Program success depends on good
systems to identify, follow, and retain all children in care.
Additional research is needed to understand the reasons
that prevent parents and guardians from returning for
results and to determine optimal ways to continue to
engage these families in HIV services.
The finding that overall 17% of HIV-exposed children
tested DNA PCR positive on their first test is consistent
with what has been observed in other programs where
single dose Nevirapine was the primary PMTCT inter-
vention [14,20,25]. However, it should be noted that 35%
of infants and 53% of mothers were recorded as not hav-
ing received any ARV intervention. Among the 282 tested
babies who were exposed to either maternal and/or infant
PMTCT ARVs 12.8% tested PCR positive, compared to
25.3% of the 154 infants where neither the mother nor the
baby received PMTCT ARVs. Where PMTCT programs
are better resourced and more efficacious PMTCT regi-
mens are given, the proportion of HIV-exposed infants
testing PCR positive is less than half what was observed
in our program [13]. The challenge in Tanzania remains
to increase uptake of ARV's for PMTCT and implement
PMTCT programs utilizing multi-drug ART regimens
which are more effective in reducing HIV transmission to
infants. In addition, 6.7% of the 45 previously PCR nega-
tive children who returned for confirmation of infection
status after weaning were PCR positive further highlight-
ing the imperative need to offer effective interventions to
prevent postnatal transmission.
The limitations of the program and this analysis
included inability to determine which HIV infected chil-
Figure 2 Time in months from birth to first HIV DNA PCR test among HIV- exposed infants testing PCR positive and PCR negative in the Tan-
zania Early Infant Diagnosis pilot program. The median age at first HIV DNA PCR testing was 4 months, IQR: 1 to 8 months, with no statistically 
significant differences in time to testing between HIV-exposed infants who tested PCR positive and those who tested PCR negative.Nuwagaba-Biribonwoha et al. BMC Pediatrics 2010, 10:44
http://www.biomedcentral.com/1471-2431/10/44
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dren initiated ART because the HIV care and treatment
clinic and EID/PMTCT clinics were run as separate pro-
grams. Furthermore, the pilot sites were purposively
selected so these results may have limited generalisability.
In addition, it was not possible to formally investigate the
reasons for the high proportion of loss to follow-up
among HIV-exposed infants in this program setting.
However, the observations in the first 6 months of imple-
mentation, particularly the critical importance of estab-
lishing EID services within health systems capable of
providing comprehensive continuous care and follow-up
of HIV-exposed infant, serve as a critical reference point
for informing the scale up of the national EID program in
Tanzania.
In conclusion, successful scale-up of EID services in
Tanzania and similar settings requires attention to the
development of adequate laboratory capacity as well as
establishment of systems to ensure appropriate long term
follow-up of HIV-exposed and infected infants.
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